APYX Apyx Medical Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: APYX

Price (delayed)

$4.335

Market cap

$181.52M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.22

Enterprise value

$189.85M

?
Relative Growth: Rel. Growth: 63
Relative Strength: Rel. Strength: 87
Relative Valuation: Rel. Valuation: 17
Relative Profitability: Rel. Profitability: 38

Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people's lives through innovative products in the cosmetic and surgical markets. Known for its innovative Helium ...

Highlights
The EPS has surged by 60% year-on-year and by 19% since the previous quarter
APYX's net income has soared by 54% year-on-year and by 18% since the previous quarter
APYX's equity is up by 22% year-on-year but it is down by 12% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://apyxmedical.com
Peers: OFIX

Key stats

What are the main financial stats of APYX

APYX stock price

How has the Apyx Medical stock price performed over time
Intraday
14.38%
1 week
4.46%
1 month
52.11%
1 year
161.14%
YTD
23.86%
QTD
17.48%

Financial performance

How have Apyx Medical's revenue and profit performed over time
Revenue
$55.9M
Gross profit
$35.3M
Operating income
-$4.31M
Net income
-$9.17M
Gross margin
63.2%
Net margin
-16.4%
Apyx Medical's operating margin has surged by 76% YoY and by 37% QoQ
APYX's operating income has surged by 72% year-on-year and by 33% since the previous quarter
APYX's net margin has soared by 61% YoY and by 23% QoQ
APYX's net income has soared by 54% year-on-year and by 18% since the previous quarter

Price vs fundamentals

How does APYX's price correlate with its fundamentals

Growth

What is Apyx Medical's growth rate over time

Valuation

What is Apyx Medical stock price valuation
P/E
N/A
P/B
14.13
P/S
3.24
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.4
The EPS has surged by 60% year-on-year and by 19% since the previous quarter
The price to book (P/B) is 109% higher than the 5-year quarterly average of 5.9 and 6% higher than the last 4 quarters average of 11.7
APYX's equity is up by 22% year-on-year but it is down by 12% since the previous quarter
The stock's price to sales (P/S) is 23% more than its last 4 quarters average of 2.3 but 14% less than its 5-year quarterly average of 3.3
The revenue is up by 18% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is Apyx Medical business performance
The return on sales has surged by 80% year-on-year and by 43% since the previous quarter
The return on invested capital has surged by 77% year-on-year and by 41% since the previous quarter
The company's return on assets has surged by 53% YoY and by 19% QoQ
Apyx Medical's return on equity has increased by 43% YoY and by 23% QoQ

Dividends

What is APYX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for APYX.

Financial health

How did Apyx Medical financials performed over time
The total assets is 26% more than the total liabilities
Apyx Medical's current ratio has increased by 16% from the previous quarter and by 6% YoY
The quick ratio is up by 12% since the previous quarter and by 3.6% year-on-year
APYX's equity is up by 22% year-on-year but it is down by 12% since the previous quarter
The company's debt to equity fell by 17% YoY but it rose by 14% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.